2. Engeler D., Messelink E.J., Baranowski A.P. et al. EAU guidelines on chronic pelvic pain. 2022. ISBN 978-94-92671-07-3. Available at: https://uroweb.org/guidelines/chronic-pelvic-pain

3. Nickel J. Prostatitis. CUA Guidelines. Canadian Urol. Assoc. J. 2011;5(5):306–315. https://www.ncbi.nlm.nih.gov/ pubmed/22031609

4. Schaeffer A.J. Classification (Traditional and National Institutes of Health) and Demographics of Prostatitisю Urology. 200;60(6 Suppl):5-6; discussion 6-7. Doi: 10.1016/s0090-4295(02)02292-6.

5. Krieger J.N., Nyberg L. Jr, Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–237.

6. Pushkar D.Yu., Segal A.S. Chronic abacterial prostatitis: a modern understanding of the problem. Vrachebnoe soslovie=Medical Caste 2004;(5-6):9–11. Russian (Пушкарь Д.Ю., Сегал А.С. Хронический абактериальный простатит: современное понимание проблемы. Врачебное сословие 2004;(5-6):9–11).

7. Tyuzikov I.A., Grekov E.A. Chronic prostatitis/chronic pelvic pain syndrome: current trends and treatment prospects from the standpoint of evidence-based medicine. Experimental and Clinical Urology 2022;15(1):90–100. Doi: 10.29188/2222-8543-2022-15-1-90-100 Russian (Тюзиков И.А., Греков Е.А. Хронический простатит/синдром хронической тазовой боли: современные тренды и перспективы лечения с позиций доказательной медицины. Экспериментальная и клиническая урология 2022;15(1):90–100 Doi: 10.29188/2222-8543-2022-15-1-90-100)

8. Bratchikov O.I., Dubonos P.A., Tyuzikov I.A., Shumakova E.A. Mechanisms of oxidative stress in the pathogenesis of chronic bacterial prostatitis (literature review). Andrology and Genital Surgery. 2022;23(3):19–28. Doi: 10.17650/2070-9781-2022-23-3-19-28 Russian (Братчиков О.И., Дубонос П.А., Тюзиков И.А., Шумакова Е.А. Механизмы окислительного стресса в патогенезе хронического бактериального простатита (обзор литературы). Андрология и генитальная хирургия. 2022;23(3):19–28. Doi: 10.17650/2070-9781-2022-23-3-19-28).

9. Gorbachev A.G., Borovets S.Yu., Al-Shukri S.H. et al. Chronic prostatitis: infectious or noninfectious? (clinical experimental research). Meditsina i obrazovanie v Sibiri = Journal of Siberian Medical Sciences 2013;(5):7–10. Russian (Горбачев А.Г., Боровец С.Ю., Аль-Шукри С.Х. и др. Хронический простатит: инфекционный или неинфекционный (клинико-экспериментальное исследование). Медицина и образование в Сибири 2013;(5):7–10).

10. Khan F.U., Ihsan A.U., Khan H.U. et al. Comprehensive overview of prostatitis. Biomed Pharmacother 2017;94:1064–1076. Doi: 10.1016/j.biopha.2017.08.016.

11. Novotny J., Oborna I., Brezinova J. et al. The occurrence of reactive oxygen species in the semen of males from infertile couples. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2003;147(2):173–176.

12. Popova A.Yu., Gamidov S.I., Ovchinnikov R.I. Use of antioxidants in a combination therapy of male infertility during inflammatory diseases. Effective pharmacotherapy. Urology and Nephrology. 2015;4(35):34–38.

13. Agarwal A., Nallela K.P., Allamaneni S.S., Said T.M. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod. Biomed. Online. 2004;8(6):616–627.

14. Zini A., De Lamirande E., Gagnon C. Low levels of nitric oxide promote human sperm capacitation in vitro. J. Androl. 1996;16(5):424–431.

15. Kelley E.E., Paes A.M.A., Yadav H. et al. Interplay between oxidative stress and metabolism in signalling and disease 2016. Oxid Med Cell Longev. 2017;2017:70–72. Doi: 10.1155/2017/7013972.

16. Lugrin J., Rosenblatt-Velin N., Parapanov R., Liaudet L. The role of oxidative stress during inflammatory processes. Biol Chem. 2014;395(2):203–20. Doi: 10.1515/hsz-2013-0241.

17. Navarro-Yepes J., Burns M., Anandhan A. et al. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal. 2014;21(1):66–85. Doi: 10.1089/ars.2014.5837.

18. Ihsan A.U., Khan F.U., Khongorzul P. et al. Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomed Pharmacother. 2018;106:714–723. Doi: 10.1016/j.biopha.2018.06.139.

19. Rees J., Abrahams M., Doble A., Cooper A. and the Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015;116:509–525. https://doi:10.1111/bju.13101

20. Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A. Combined drug therapy of patients with BPH. Urologiia. 2018;1:101–105. Russian (Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Комбинированная медикаментозная терапия больных аденомой простаты. Урология. 2018;1:101–105).

21. Gyaurgiev T.A., Kuzmenko A.V., Kuzmenko V.V. The efficiency of various cytokine therapy regimens in the complex treatment of men with chronic abacterial prostatitis. Urologiia. 2023;(1):12–19. Russian (Гяургиев Т.А., Кузьменко А.В., Кузьменко В.В. Эффективность различных схем цитокинотерапии в комплексном лечении мужчин с хроническим абактериальным простатитом. Урология. 2023;(1):12–19).

22. Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A., Barannikov I.I. Chronobiological status of patients with chronic prostatitis on the background of prostate adenoma. System analysis and management in biomedical systems. 2017;16(3):513–316. Russian (Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А., Баранников И.И. Хронобиологический статус больных хроническим простатитом на фоне аденомы предстательной железы. Системный анализ и управление в биомедицинских системах. 2017;16(3):513–316).

23. Thakkinstian A., Attia J., Anothaisintawee T., Nickel J.C. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2012;110(7):1014–1022.

24. Bozhedomov V.A. Modern opportunities for the treatment of chronic prostatitis. Andrologiya i genital’naya khirurgiya=Andrology and Genital Surgery 2016;17(3):10–22. Russian (Божедомов В.А. Современные возможности лечения хронического простатита. Андрология и генитальная хирургия 2016;17(3):10–22).

25. Kalghatgi S., Spina CS, Costello J.C. et al. Bactericidal antibiotics iduce mitihindrial dysfunction and oxidative damage in Mammalian cells. Sci Transi Med. 2013;5(192):85–89.

26. Nickel J.C., Narayan P., MacKay J. et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. Urology. 2004;171(4):1594–1597.

27. Тkachenko Е.V. Application of Movalis suppositories in the urologist's ambulance situation. Vrach= Physician 2010;(1):65–67. Russian (Ткачен-ко Е.В. Применение свечей мовалис в амбулаторной практике врача-уролога. Врач 2010;(1):65–67).

28. Neymark А.I., Yakovets Ya.V., Аliev R.Т. Experience of Nise (Nimesulide) use in the comprehensive treatment of patients with chronic abacterial prostatitis with chronic pelvic pain syndrome. Urologiya=Urology 2004;(5):31–34. Russian (Неймарк А.И., Яковец Я.В., Алиев Р.Т. Опыт использования найза (нимесулид) в комплексном лечении больных хроническим абактериальным простатитом с синдромом хронической тазовой боли. Урология. 2004;(5):31–34).

29. Rui-Min Han, Jian-Ping Zhang, Leif H. Reaction Dynamics of Flavonoids and Carotenoids as Antioxidants Molecules. 2012;17(2):2140–2160.

30. Demmig-Adams B., Adams W.W., III. Antioxidants in photosynthesis and human nutrition. Science. 2002;298:2149–2153. Doi: 10.1126/science.1078002.

31. Pietta P.G. Flavonoids as Antioxidants. J. Nat. Prod. 2000;63:1035–1042. Doi: 10.1021/np9904509.

32. Paiva S.A., Russell R.M. β-Carotene and other carotenoids as antioxidants. J. Am. Coll. Nutr. 1999;18:426–433.

33. Chiryapkin A.S., Zolotykh D.S., Pozdnyakov D.I. Review of the biological activity of flavonoids: quercetin and kaempferol. Juvenis scientia. 2023;9(2):5–20. Doi: 10.32415/jscientia_2023_9_2_5-20. EDN: WING. Russian (Чиряпкин А.С., Золотых Д.С., Поздняков Д.И. Обзор биологической активности флавоноидов: кверцетина и кемпферола. Juvenis scientia. 2023;9(2):5–20. Doi: 10.32415/jscientia_2023_9_2_5-20. EDN: WCLBZG).

34. Xu D., Hu M.-J., Wang Y.-Q., et al. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules. 2019;24(6):1123. Doi: 10.3390/molecules24061123.

35. Zhang M., Swartz S.G., Yin L., et al. Antioxidant Properties of Quercetin. Advances in Experimental Medicine and Biology. 2011;701:283–298. Doi: 10.1007/978‑1‑4419‑7756‑4_3.

36. Mlcek J., Jurikova T., Skrovankova S., et al. Quercetin and Its Anti-Allergic Immune Response. Molecules. 2016;21(5):623. Doi: 10.3390/molecules21050623.

37. Chirumbolo S. The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function. Inflammation & Allergy. Drug Targets. 2010;9(4):263–285. Doi: 10.2174/187152810793358741.

38. Hung C.F., Huang T.F., Chen B.H. et al. Lycopene inhibits TNF‐alpha‐induced endothelial ICAM‐1 expression and monocyte‐endothelial adhesion. Eur J Pharmacol 2008;586:275–282.

39. Napolitano M., De Pascale C., Wheeler-Jones C. et al.Effect of lycopene on the induction of foam cell formation by modified LDL. Am J Physiol Endocrinol Metab 2007;293:1820–1827.

40. Ono M., Takeshima M., Nakano S. Mechanism of the anticancer effect of lycopene (tetraterpenoids). Enzymes. 2015;37:139–166.

41. Bhuvaneswari V., Valmurugan B., Nagini S. Dose-response effect of tomato paste on 7,12-dimethylbenz

42. Ben-Dor A., Steiner M., Gheber L. et al. Carotenoids activate the antioxidant response element transcription system. Mol. Cancer Ther. 2005;4:177–186.

43. Zhang B., Gu Y. Low expression of ERK signaling pathway affecting proliferation, cell cycle arrest and apoptosis of human gastric HGC-27 cells line. Mol. Biol. Rep. 2014;41:3659–3669.

44. Velmurugan B., Mani A., Nagini S. Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis.Eur. J. Cancer Prev. 2005;14:387–393.

45. Palozza P., Simone R., Catalano A. Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression. J. Nutr. Biochem. 2011;22:259–268.

46. Van Poppel H., Tombal B. Chemoprevention of prostate cancer with nutrients and supplements. Cancer Manag. Res.2011;3:91–100.

47. Schwarz S., Obermüller-Jevic U.C., Hellmis E. et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 2008;138:49–53.

48. Ravetti S., Garro A.G., Gaitán A., Murature M., Galiano M., Brignone S.G., Palma S.D. Naringin. Encyclopedia. Available online: https://encyclopedia.pub/entry/42479 (accessed on 26 February 2024).

49. Ghanbari-Movahed M., Jackson G., Farzaei M.H., Bishayee A. A systematic review of the preventive and therapeutic effects of naringin against human malignancies. Front. Pharmacol. 2021;12:639840.

50. Miles E.A., Calder P.C. Effects of citrus fruit juices and their bioactive components on inflammation and immunity: A narrative review. Front. Immunol. 2021;12:712608.